Recombinant hemoglobins as artificial oxygen carriers

Area of Science:

• Biochemistry
• Biotechnology
• Medical Science

Background:

• Hemoglobin (Hb) and myoglobin (Mb) are crucial for oxygen transport.
• Hb-based oxygen carriers (HBOCs) face challenges like extravasation and vasoactivity.
• Modifying Hb/Mb structure is key to overcoming these limitations.

Purpose of the Study:

• To engineer mutant hemoglobins with altered oxygen affinities.
• To create polymeric hemoglobins and myoglobins to prevent extravasation and vasoactivity.
• To evaluate the in vivo efficacy and safety of these engineered proteins.

Main Methods:

• Site-directed mutagenesis to create Hb and Mb variants.
• Polymerization techniques to form high molecular weight aggregates.
• In vivo exchange transfusion studies in mouse models.
• Assessment of oxygen carrying capacity and vasoactivity.

Main Results:

• Successfully constructed mutant hemoglobins with varying oxygen affinities.
• Developed polymeric hemoglobins and myoglobins that resist extravasation.
• In vivo testing showed no vasoactivity associated with polymeric Hb transfusion in mice.
• Polymeric hemoglobins effectively delivered oxygen to ischemic tissues.

Conclusions:

• Engineered polymeric hemoglobins and myoglobins offer a promising solution for HBOCs.
• Polymerization effectively mitigates Hb-related extravasation and vasoactivity.
• These modified proteins serve as efficient oxygen carriers for ischemic tissues, independent of specific oxygen affinity.